Due to the ability of biglycan to affect ROS production via TLR2 and TLR4 in a NOX1- and NOX4-dependent manner (166, 168) (Figure 2), it is very likely that biglycan potentially influences tumor angiogenesis via ROS level regulation. Here, TLR2 is linked to neoplasm.